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Abstract
Pancreatic stellate cells (PaSCs) are cells that are located around the acinar,
ductal, and vasculature tissue of the rodent and human pancreas, and are responsible
for regulating extracellular matrix (ECM) turnover and maintaining the architecture of
pancreatic tissue. This study examines the contributions of integrin receptor signaling
in human PaSC function and survival. Human PaSCs were isolated from pancreata
collected during the 2nd trimester of pregnancy and identified by expression of stellate
cell markers, ECM proteins and associated growth factors. Multiple integrins are
found in isolated human PaSCs, with high levels of β1, α3 and α5. Cell adhesion and
migration assays demonstrated that human PaSCs favour collagen I matrix, which
enhanced PaSC proliferation and increased TGFβ1, CTGF and α3β1 integrin. Significant
activation of FAK/ERK and AKT signaling pathways, and up-regulation of cyclin D1
protein levels, were observed within PaSCs cultured on collagen I matrix. Blocking
β1 integrin significantly decreased PaSC adhesion, migration and proliferation,
further complementing the aforementioned findings. This study demonstrates that
interaction of β1 integrin with collagen I is required for the proliferation and function
of human fetal PaSCs, which may contribute to the biomedical engineering of the ECM
microenvironment needed for the efficient regulation of pancreatic development.

INTRODUCTION

receptors and various ECM components in the developing
human pancreas.
Integrins are cell adhesion receptors that play an
integral role in cell-cell and cell-ECM communication in
many cell types, including rodent PaSCs. Among integrin
receptors, β1 integrin associates with 12 α subunits [6]
and mediates cellular binding to multiple extracellular
matrix proteins (i.e., collagens, laminin, fibronectin)
[7]. Stimulation of β1 integrin down-stream signaling
pathways are important for cell migration, differentiation,
proliferation, and survival [7-9]. Our recent study
elucidated the functional role of β1 integrin in PaSCs
using an inducible β1 integrin knockout mouse model

Pancreatic stellate cells (PaSCs) are non-endocrine,
mesenchymal-like cells [1-3] that reside in the periacinar, peri-ductal and peri-vascular area and play a role
in regulating extracellular matrix (ECM) turnover, which
is important for maintaining the integrity of pancreatic
tissues architecture [4]. In the adult human pancreas, there
is emerging evidence that interplay between PaSCs and the
surrounding ECM is required for pancreatic tissue repair
and involved in pathophysiological processes including
inflammation and pancreatic fibrosis [5]. However, little
is known about the interaction between PaSCs integrin
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[10]. We found that β1 integrin deficiency in collagen
I-producing PaSCs impaired basement membrane integrity
and function with loss of ECM expression in the pancreas,
which in turn affected acinar cell proliferation and function
[10]. The connective tissue growth factor (CTGF), a
known activator of PaSCs, requires α5β1 integrin to
promote rat PaSCs adhesion, migration, proliferation, and
cytokine secretion [11]. In the developing human pancreas,
the α3β1 integrin is highly expressed in fetal islet cells and
co-localizes with collagen IV [12]. Interactions between
α3β1 and collagen I or IV activate both the MAPK/ERK
and the PI3K/AKT signaling pathways, suggesting that
they are critical for modulating islet cell differentiation,
proliferation, and survival in the developing human
pancreas [13]. Despite these previous studies, the
functional role of β1 integrin directly affecting PaSCs in
the developing human pancreas has yet to be examined.
In this study, PaSCs were isolated from human fetal
pancreata collected during the 2nd trimester of pregnancy
and characterized as follows: the expression pattern of β1
integrin associated with α subunits in human PaSCs were
examined, and cell behaviors such as adhesion, migration,
proliferation, and function were studied following

exposure to various matrix proteins. Our results revealed
that the collagen I matrix increased α3β1 integrindependent PaSC adhesion and migration, enhanced PaSC
proliferation, and increased TGFβ1 and CTGF production
via activation of the FAK/ERK and AKT signaling
pathways. Similar results were obtained when using a β1
integrin blockade study. This study demonstrated that β1
integrin association with α3 integrin is required for the
proliferation and proper function of human fetal PaSCs
on a collagen I matrix, and provide a better understanding
of PaSC-ECM interactions in the developing human
pancreas.

RESULTS
Characterization of purified human fetal PaSCs
Using a modified outgrowth method [14], human
fetal PaSCs were outgrown to form monolayers within
3 weeks of the culture, where the phase-contrast (PH)
micrograph of quiescent PaSCs for lipid droplet content

Figure 1: Characterization of isolated human fetal PaSCs. A. Phase-contrast micrographs of quiescent human fetal PaSCs. Scale
bar: 50μm. Arrows indicate lipid droplets in PaSCs. B. Representative images of immunofluorescence staining for PaSC markers: desmin,
vimentin, GFAP, and αSMA, along with ECM proteins: collagen I and IV, laminin, and fibronectin (green). Both CK19 (ductal cell marker)
and stromal cell surface marker were not expressed in the human fetal PaSCs. Nuclei were stained with DAPI (blue). Scale bar: 50μm.
Magnified images for desmin and vimentin are shown in the insets. Western blot analyses of PaSC markers C. and growth factors (TGFβ1
and CTGF) D. from cultured human fetal PaSCs, between passages 2 to 5 (n = 5-6 experiments/group). Representative blots are shown.
www.impactjournals.com/oncotarget
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Integrin expression in human fetal PaSCs

was used to confirm PaSC phenotype (Figure 1A). The
purity of PaSCs was assessed by immunofluorescence
staining and western blot analysis, and showed positive
labeling for stellate cell selective markers (desmin,
vimentin, GFAP, and αSMA), but not for cytokeratin 19
(a ductal cell marker) and stromal cell surface marker
(Figure 1B). The matrix proteins, collagen I and IV,
laminin, and fibronectin, were also expressed in isolated
human PaSCs (Figure 1B). Western blot analyses further
verified PaSCs markers (Figure 1C), and growth factors
(TGFβ1 and CTGF) in cultured human PaSCs from 2 to
5 passages (Figure 1D). This data indicates that purified
PaSCs isolated from human fetal pancreata could be used
for the following experiments.

β1 and β3 integrins and their associated α subunits,
including α1-3, α5-6, and αv, were examined in isolated
human PaSCs. Immunofluorescence staining of PaSCs
showed the expression of α1-3, α5-6 and αv subunits
along with β1 integrin, with relatively lower expression
of β3 (Figure 2A). The staining data was corroborated
with western blot analysis that showed higher levels of β1
integrin with α3 and α5 subunits (Figure 2B). These data
suggest that α3β1 and α5β1 may play an integral role in
the function and proliferation of human fetal PaSCs.

Figure 2: Integrin expression in human fetal PaSCs. A. Representative images of immunofluorescence staining for α1-3, α5-6, αv,
β1 and β3 integrin (green) in cultured human fetal PaSCs. Nuclei were stained with DAPI (blue). Scale bar: 50μm. B. Western blot of α and
β1 integrin expression in cultured human fetal PaSCs. Data are expressed as means ± SEM (n = 5-6 experiments/group). Representative
blots are shown.
www.impactjournals.com/oncotarget
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Collagen I, IV, and fibronectin matrix proteins
enhance PaSC adhesion and migration

adhesion when compared to PaSCs on collagen I (p <
0.05, Figure 3B), with no significant difference compared
to control (Figure 3B). To examine PaSC migration on
these matrices, near confluent cell monolayers were
wounded to form a gap and migration distance over the
gap of PaSCs was measured after 24 hours. It was found
that PaSC migration was enhanced on both collagens I and
IV, and the gaps were closed completely within 24 hours
(Figure 3C). However, gaps remained open on fibronectin,
laminin, and control groups (Figure 3C), suggesting that
human fetal PaSC migration is favored when cultured on
collagen matrices.

The common ligands for α3β1 integrin are
fibronectin, laminin, collagen I, and collagen IV [15,16],
while fibronectin is the ligand for α5β1 integrin [1719]. The adhesion of PaSCs to these common matrix
components was examined individually. PaSCs showed
strong adhesion to collagen I, collagen IV, and fibronectin
within 20 minutes (Figure 3A), and the number of adherent
cells increased by at least 3-fold with these matrix
components compared to control (p < 0.05-0.01, Figure
3B). PaSCs plated on laminin showed relatively lower

Figure 3: Collagen I, collagen IV, and fibronectin enhance PaSC adhesion and migration. A. Phase-contrast micrographs of

human fetal PaSCs plated on collagen I (Col I), IV (Col IV), fibronectin (FN), laminin (L) or BSA coated control (Ctrl) for 20 mins. B. The
cell adhesion rate on various ECM matrices after 20 minutes. Data are expressed as means ± SEM (n = 4 experiments/group). *p < 0.05,
**p < 0.01 vs. control, and analyzed by one-way ANOVA followed by Tukey’s post-hoc analyses. C. Phase-contrast micrographs of human
fetal PaSC migration from wounded gaps at 0 and 24 hours on various ECM matrices. Scale bar: 100μm. Representative images are shown.
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Evaluation of the effect of collagen I on PaSC
proliferation

analyzed by immunofluorescence staining for nuclear
Ki67 labeling (Figure 4A), and showed a significantly
increased percentage of Ki67+ PaSCs when compared to
control (p < 0.05, Figure 4A). Both TGFβ1 and CTGF
are key growth factors produced by PaSCs that stimulate
the synthesis and secretion of ECM proteins (collagen,
fibronectin, and laminin) [20,21], and were significantly
increased (TGFβ1, p < 0.01, Figure 4B; CTGF, p < 0.05,
Figure 4C) in PaSCs when compared to the control group.

Given that PaSCs cultured on collagen I
demonstrated increased PaSC adhesion and migration,
the proliferation, growth factors productions (i.e., TGFβl
and CTGF) and associated signaling pathways were
examined. The proliferative capacity of PaSCs was

Figure 4: Collagen I increases PaSC proliferation and growth factor production. A. Representative images of
immunofluorescence staining and quantitative analysis of Ki67+ (red) for PaSCs cultured on a control plate with BSA or collagen I matrix
for 24 hours. Nuclei were stained with DAPI (blue). Scale bar: 25μm. Western blot analyses of TGFβ1 B. and CTGF C. protein levels in
PaSCs cultured on control plate with BSA or collagen I matrix after 24 hours. Representative blots are shown. Data are expressed as means
± SEM (n = 4-5 experiments/group). *p < 0.05, **p < 0.01 vs. control, and analyzed by paired Student’s t-test.
www.impactjournals.com/oncotarget
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Collagen I is a major activator of α3β1 integrin,
and therefore was further examined to determine if
PaSCs cultured on collagen I could enhance α3 and β1
integrin expression and stimulate its downstream signaling
molecules involved in PaSC proliferation and function.
It was noted that both β1 (p < 0.01, Figure 5A) and α3
(p < 0.05, Figure 5B) protein levels were significantly
increased when PaSCs were cultured on collagen I,
along with elevated phospho-FAK (p < 0.05, Figure 5C)

compared to the control group. Increasing activation of
α3β1/FAK resulted in a significant increase of phosphoERK1/2 (p < 0.01, Figure 5D) and phospho-AKT (p <
0.01, Figure 5E), along with an increase of cyclin D1 (p <
0.01, Figure 5F) protein expression, in PaSCs. This data
indicates that interaction of α3β1 integrin with collagen
I could lead to activation of downstream FAK/ERK and
AKT, along with cyclin D1 signaling pathways, resulting
in increased PaSC proliferation and function.

Figure 5: Collagen I enhances PaSC α3β1 integrin expression and downstream FAK/ERK, AKT, and cyclin D1
signaling. Western blot analyses of β1 A. and α3 B. integrins, phosphorylated [P] and total [T] FAK C., ERK D., AKT E., and cyclin D1

F. protein levels of PaSCs cultured on a control plate with BSA or collagen I matrix after 24 hours. Data are expressed as means ± SEM
(n = 4-5 experiments/group). Representative blots are shown. *p < 0.05, **p < 0.01 vs. control, and analyzed by paired Student’s t-test.
www.impactjournals.com/oncotarget
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Blocking β1 integrin reduces collagen I stimulated
PaSC function and proliferation

left untreated and plated on a collagen I matrix. PaSCs
treated with anti-β1 integrin displayed a 50% reduction
in cell adhesion to collagen I when compared with IgG
and control groups, respectively (p < 0.01-0.001, Figure
6A). Functional blockade of β1 integrin on PaSCs
severely hampered their ability to migrate and cover
the gaps on collagen I matrix (Figure 6B). No apparent
difference in PaSC adhesion and migration was observed

To determine how β1 integrin is involved in
regulating the adhesion and migration of PaSCs via the
binding of collagen I, human fetal PaSCs were pretreated
with human β1 immunoneutralizing antibody, IgG, or

Figure 6: β1 integrin blockade reduces PaSC adhesion and migration on collagen I. A. Phase-contrast micrograph of human

fetal PaSC adhesion and quantitative analyses of PaSC adhesion rate in anti-β1 integrin, IgG, and control experimental groups cultured on
a collagen I matrix after 20 minutes. Data are expressed as means ± SEM (n = 3 experiments/group). *p < 0.05, **p < 0.01 vs. control, and
analyzed by one-way ANOVA followed by Tukey’s post-hoc analyses. B. Phase-contrast micrographs of human fetal PaSC migration from
wounded gaps at 0 and 24 hours on collagen I matrix. Scale bar: 100μm. Representative images are shown.
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and CTGF (p < 0.05-0.01, Figure 7C) protein levels when
compared to the controls. This β1 integrin blocking study
indicates that β1 integrin interactions with the collagen I
are essential for maintaining human fetal PaSC adhesion,
migration, proliferation, and production of certain growth
factors.

between IgG and control groups (Figure 6A and 6B). A
significant decrease of Ki67+ labeling in PaSCs cultured
on a collagen I matrix was observed following anti-β1
integrin treatment when compared to controls (p < 0.01,
Figure 7A). Furthermore, blocking β1 integrin on PaSCs
showed relatively reduced TGFβ1 (p < 0.05, Figure 7B)

Figure 7: β1 integrin blockade decreases PaSC proliferation and associated growth factor levels. A. Representative images
of immunofluorescence staining and quantitative analyses of Ki67+ (red) PaSCs in anti-β1 integrin, IgG and control experimental groups
cultured on a collagen I matrix for 24 hours. Nuclei were stained with DAPI (blue). Scale bar: 25μm. Western blot analysis of PaSC TGFβ1
B. or CTGF C. protein levels in anti-β1 integrin, IgG, and control experimental groups cultured on collagen I for 24 hours. Representative
blots are shown. Data are expressed as means ± SEM (n = 3-5 experiments/group). *p < 0.05 and **p < 0.01 vs control group, and data
were analyzed by one-way ANOVA followed by Tukey’s and Fisher’s least significant difference post-hoc analyses.
www.impactjournals.com/oncotarget
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Perturbing β1 integrin function decreases FAK
and ERK1/2, but not AKT activation in PaSCs
cultured on a collagen I matrix

(Figure 8B) integrin. However, a significant reduction
in the phosphorylation of FAK (p < 0.05, Figure 8C)
and phospho-ERK (p < 0.05-0.01, Figure 8D), but not
AKT (Figure 8E), signaling pathways was observed in
the anti-β1 PaSC group. This data corroborates with our
previous study using human fetal islet-epithelial cells [13].
Additionally, down-regulation of FAK/ERK signaling
pathways in PaSCs induced by β1 integrin blockade led
to reduced cyclin D1 expression (p < 0.05-0.01, Figure
8F). This data further indicates that β1 integrin-collagen I
interactions are critical for modulating PaSC proliferation
and function through specialized signaling cascades.

Since collagen I promoted PaSC proliferation
and production of TGFβ1 and CTGF via the α3 and β1
integrin-stimulated MAPK and PI3K pathways, we
examined whether blocking β1 integrin impeded PaSC
function and survival via the same pathways. Blocking
β1 integrin on PaSCs cultured on a collagen I matrix did
not affect the protein levels of β1 (Figure 8A) and α3

Figure 8: β1 integrin blockade decreases FAK, ERK1/2 and cyclin D1 signaling in PaSCs. Western blot analyses of β1
A. and α3 B. integrins, phosphorylated [P] and total [T] FAK C., ERK D., AKT E., and cyclinD1 F. protein levels of PaSCs cultured on
collagen I in anti-β1 integrin, IgG, and control experimental groups. Data are expressed as means ± SEM (n = 3-5 experiments/groups).
Representative blots are shown. *p < 0.05 and **p < 0.01 vs control group, and analyzed by one-way ANOVA followed by Tukey’s posthoc analyses.
www.impactjournals.com/oncotarget
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DISCUSSION

collagen I, specifically through α3β1 integrin. In contrast
to human fetal PaSCs, α5β1 integrin is required for rat
adult PaSC adhesion and migration on fibronectin under
the CTGF stimulation [11], and blocking α5β1 integrin
led to inhibited rat adult PaSC activation and function
[33]. In hepatic stellate cells (HSCs), the interaction of
β3 integrin with collagen I is required for HSC migration
and survival, while inhibition of β3 integrin is sufficient
for inducing HSC apoptosis and halting cell migration
on collagen I matrix [34]. The differences in the integrin
subunits and ECM interactions seen in the current PaSC
study compared to others could be due to the cell types
(HSCs vs. PaSCs), ages (fetal vs. adult), and species
(human vs. rat). Our data demonstrated that the interaction
between α3β1 integrin and the ECM protein collagen I is
essential for the proliferation and function of human fetal
PaSCs in vitro.
Importantly, the current findings were in agreement
with previous reports showing that β1 integrin is
predominately expressed in PaSCs [11]. Our previous
study also showed that mice with β1 integrin deficiency
under control of the collagen I promoter directly affected
PaSC function and survival [10]. Using a neutralizing
antibody to block β1 integrin activity on human fetal
PaSCs, we found significantly inhibited cell adhesion,
migration, proliferation, and growth factor production,
along with reduced phosphorylation of the FAK/ERK and
downstream cyclin D1 signaling that was independent
of PI3K/AKT activation. In several model systems,
β1 integrin has been shown to activate the FAK/ERK
signaling cascade to enhance cell survival and function
[35, 36]. Neutralizing antibodies against β1 and α3 integrin
subunits could inhibit collagen I-induced activation of
the FAK/ERK pathway in ovarian cancer cell lines [37];
however, enhanced activation of β1 integrin promotes
phosphorylation of FAK, as seen in studies examining
human lung fibroblasts viability [38-40]. Mantoni et al.
[41] determined that PaSCs protect pancreatic cancer
cells that had escaped from radiation through β1 integrin
signaling via the FAK, but not the PI3K/AKT pathway. In
addition, Lu et al. [42] found in their PaSC-induced cancer
cell migration study that collagen I is the major factor to
enhance α2β1 integrin expression, which lead to activation
of the FAK signaling pathway. Our previous in vitro
studies also demonstrated that collagen I promoted human
fetal islet cell differentiation and proliferation through
β1 integrin via downstream FAK/ERK phosphorylation
[13], while only α3 integrin mediated signaling through
the PI3K/AKT pathway [43]. Furthermore, β1 integrin
signaling via the FAK/ERK pathway was verified in a
mouse model with a collagen I-producing cell specific
β1 integrin deficiency; these mice exhibited a severe loss
of β-cell mass, suggesting that β1 integrin/FAK/ERK
signaling is required for PaSC functions involved in β-cell
differentiation and survival [10, 44]. Taken together, our
present findings demonstrate that the β1 integrin/FAK/

In the present study, we have isolated and purified
human PaSCs from developing pancreata and have
demonstrated that β1 integrin and its associated α3 subunit
is highly expressed in human fetal PaSCs. The activation
of α3β1 integrin by collagen I matrix protein plays an
important role in mediating human fetal PaSC adhesion,
migration, proliferation, and growth factor production.
Culturing human fetal PaSCs on collagen I not only
enhanced α3β1 integrin expression, but also altered the
integrin/FAK and downstream ERK and AKT signaling
pathways, along with elevating cyclin D1 protein levels.
Blocking β1 integrin on PaSCs resulted in significant
down regulation of the FAK/ERK/cyclin D1 signaling
pathways with no effect on the AKT pathway. This study
provides the first ex vivo delineation of the mechanisms
by which interaction of β1 integrin with collagen I protein
regulates human fetal PaSC function and growth.
Using a modified PaSC isolation and purification
protocol [14, 22], we showed that the stellate-like cells
derived from the isolated human fetal pancreas expressed
specific stellate markers including desmin, vimentin,
GFAP, and αSMA, paired with the absence of CK19
and stromal cell markers, suggesting that ductal cells
and mesenchymal stromal cells were not present as
contaminants in isolated human PaSC populations [2325]. More importantly, our purified human PaSCs retained
functionality to produce various ECM and growth factors
for at least 10 population doublings. Given this efficient
method in isolating human fetal PaSCs, this study provided
a sufficient cell number to elucidate PaSC function and
PaSC-induced pancreatic diseases [26, 27], and also
offers a novel opportunity to study PaSCs in pancreatic
morphogenesis [10] and endocrine differentiation [28, 29]
during pancreatic development.
To date there is insufficient available information
regarding the expression of integrins on PaSCs in the
developing human pancreas, although α5β1 integrin
expression in rat adult PaSCs has been previously
reported [11]. The present study examined the integrins
associated with isolated human fetal PaSCs, and showed
predominately high levels of α3β1 and α5β1. Examination
of the relationship between ECM proteins and integrins
required for human fetal PaSC adhesion and migration,
demonstrated that collagen I plays a significant role
through α3β1 integrin signaling. Culturing human fetal
PaSCs on a collagen I matrix not only resulted in increased
PaSC proliferation, but also significantly increased TGFβ1
and CTGF protein levels. Both TGFβ1 and CTGF are
released by PaSCs and act upon PaSCs via autocrine
signaling to control migration, proliferation, synthesis
and secretion of ECM proteins [30-32]. Thus, increasing
TGFβ1 and CTGF protein levels in cultured human
PaSCs could promote a positive feedback loop to enhance
cell adhesion, migration, and secretion in response to
www.impactjournals.com/oncotarget
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were removed by washing the wells twice with sterile
phosphate buffered saline (PBS). Six random fields per
well were imaged at 40X magnification using an inverted
light microscope (Leica DM IL; Leica Microsystems Inc.,
Concord, ON, Canada) and analyzed with Image ProPlus
software (Media Cybernetics Inc., Rockville, MD, U.S.A).
Adhered cells were counted manually, and data were
expressed as fold change versus control.
To measure the migration rate of PaSCs, a woundhealing assay was adopted [45]. 1x104 PaSCs/well were
plated on 96-well tissue culture plate pre-coated with 5μg/
ml of either collagen I, collagen IV, fibronectin, laminin,
or control in serum-free media for 24 hours. After reaching
confluence, the monolayers were wounded by scraping
using a 10μl pipette tip and incubated with serum-free
media for an additional 24 hours [45]. In each well,
images of three different segments of the ‘wound’ area
were captured 0 hour and 24 hours after damage. Each
experiment was conducted in triplicate with at least four
repeat experiments per group.

ERK signaling pathway is critical for human fetal PaSC
function and survival.
In summary, the present study provides insight into
the expression of integrin receptors in human fetal PaSCs
and sheds light on how the β1 integrin, in association
with its binding partner α3 subunit, interacts with the
ECM protein collagen I and plays multiple roles in PaSC
biology. β1 integrin interacts with the ECM to activate the
FAK and ERK signaling pathway, which are important in
maintaining proper PaSC function, along with increased
cyclin D1 that leads to PaSC proliferation. These findings
indicate that β1 integrin is required for the function and
proliferation of human fetal PaSCs, and future applications
of this research could contribute to the biomedical
engineering of the ECM microenvironment needed for the
efficient regulation of pancreatic development.

Materials and METHODS
Human fetal PaSCs isolation and culture

Blocking of β1 integrin using immunoneutralizing
antibody

Human fetal pancreata (17-21 weeks fetal age)
were collected according to protocols approved by the
Health Sciences Research Ethics Board at the University
of Western Ontario, in accordance with the Canadian
Council on Health Sciences Research Involving Human
Subjects guidelines. Pancreatic tissues were carefully
dissected from surrounding tissues and immediately
digested using dissociation buffer containing collagenase
V (1 mg/ml; Sigma, St. Louis, MO, USA), followed
by filtration through a 250 µm nylon mesh to yield fine
cell-clusters [22]. PaSCs were isolated from dissociated
human fetal pancreatic cell clusters using a modified
outgrowth method as described previously [14]. In brief,
cell clusters were seeded in uncoated culture T25 flasks
(Fisher Scientific, Ottawa, ON, Canada) and cultured in
Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s
F12 (1:1 v/v) containing 10 % fetal bovine serum (FBS,
Invitrogen, Burlington, ON, Canada). Eighteen hours after
seeding, culture medium was changed with moving nonadhered cell clusters. The PaSCs grew out from the cell
clusters over a 72 hours period. PaSC purity was assessed
after the 2nd passage by immunofluorescence staining and
western blot analysis for stellate cell selective markers.

PaSCs were pre-incubated with either anti-human β1
integrin antibody (CD29, 5μg/ml), human IgG2a isotypematched negative control (5μg/ml, BD Biosciences, San
Diego, CA, USA), or fresh media (DMEM/Ham’s F12 plus
1% BSA) for 1 hour prior to seeding on collagen I (5μg/
ml) pre-coated tissue culture plates [9, 12, 13, 43]. Cells
were then cultured with DEMEM/Ham’s F12 plus 1%
BSA media for 24 hours. At the end of the culture period,
cells were subjected to adhesion and migration assays, or
harvested for protein preparation or immunocytochemical
studies. All culture experiments were conducted in
triplicate with at least 3 repeat experiments per group.

Immunofluorescence staining
For in-situ cell staining, PaSCs were cultured on
coverslips (Fisher Scientific) pre-coated with poly-Llysine (Sigma) for 1-3 days. Immunofluorescence staining
was conducted using the antibodies as listed in Table 1.
For quantitative analysis of Ki67 labeling in
PaSCs, experimental cell groups at the end of the culture
were harvested and fixed in 4% PFA, embedded in 2%
agarose gel and processed into tissue blocks [43]. Cell
sections (4μm) were stained for Ki67 and nuclei were
counterstained with DAPI. The percentage of Ki67+ cells
was calculated by counting at least 500 cells per section
per experimental group, with a minimum of 3 repeat
experiments per group.

Adhesion and migration assay
For the adhesion assay, 1x103 PaSCs/well were
plated on 96-well tissue culture plate pre-coated with
5μg/ml of either collagen I, collagen IV (BD Biosciences,
Mississauga, ON, Canada), fibronectin, laminin
(Chemicon, Temecula, CA, USA), or control (1% BSA,
Sigma) in serum-free DEMEM/Ham’s F12 (1:1 v/v)
plus 1% BSA media for 20 minutes. Non-adhered cells
www.impactjournals.com/oncotarget
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Table 1: List of antibodies used for immunofluorescence and/or western blotting analysis

a

Primary Antibody
Mouse antiα-Smooth Muscle Actin

Dilution

Company, Location

1:50a or 1:1000

Dako, Mississauga, ON, Canada

Mouse anti-Vimentin

1:200a or 1:3000

Millipore, Temecula, CA, USA

Mouse anti-GFAP

1:50 or 1:500

BD Pharmingen, Mississauga, ON, Canada

Rabbit anti-Desmin

1:100 or 1:1000

Abcam, Cambridge, MA, USA

Mouse anti-collagen I

1:50a

Santa Cruz, Montreal, QC, Canada

Mouse anti-collagen IV

1:100a

Rabbit anti-Laminin

1:100a

Mouse anti-Fibronectin

1:100a

Chemicon, Temecula, CA, USA
Developmental Studies Hybridoma Bank, Iowa
City, IA, USA
Chemicon, Temecula, CA, USA

Mouse anti-CK19
Mouse antiStromal cell surface marker
Mouse anti-β1

1:50a

1:100a or 1:1000

Dako, Mississauga, ON, Canada
Developmental Studies Hybridoma Bank, Iowa
City, IA, USA
Chemicon, Temecula, CA, USA

Rabbit anti-β3

1:50a

Abcam, Cambridge, MA, USA

Rabbit anti-α1

1:50a

Santa Cruz, Montreal, QC, Canada

Rabbit anti-α2

1:100a or 1:2000

Santa Cruz, Montreal, QC, Canada

Rabbit anti-α3

1:200 or1:2000

Chemicon, Temecula, CA, USA

Rabbit anti-α5

1:500 or 1:5000

Chemicon, Temecula, CA, USA

Rabbit anti-αV

1:200aor 1:2000

Santa Cruz, Montreal, QC, Canada

Mouse anti-Ki67

1:100a

BD Pharmingen, Mississauga, ON, Canada

Mouse anti-phosphorylated Akt
(Ser 473)
Rabbit anti-Akt
Rabbit anti-phosphorylated
Thr202/Tyr204 ERK12
Rabbit anti-ERK1/2
Rabbit
anti-phosphorylated
FAK
(Try397)
Rabbit anti-FAK

1:2000

Cell Signaling, Danvers, MA, USA

1:2000

Cell Signaling, Danvers, MA, USA

1:2000

Cell Signaling, Danvers, MA, USA

1:1000

Cell Signaling, Danvers, MA, USA

1:2000

Abcam, Cambridge, MA, USA

1:3000

Cell Signaling, Danvers, MA, USA

Mouse anti-CyclinD1

1:2000

Cell Signaling, Danvers, MA, USA

Rabbit anti-TGF-β1

1:1000

Sigma, St Louis, MO, USA

Goat anti-CTGF

1:1000

Santa Cruz, Montreal, QC, Canada

Mouse anti-Calnexin

1:2000

BD Biosciences, Mississauga, ON, Canada

Rabbit anti-GAPDH

1:2000

Santa Cruz, Montreal, QC, Canada

a
a

1:50a

a

a

dilution factor used for immunofluorescence

Protein extraction and western blotting

and transferred onto a nitrocellulose membrane (Bio-Rad
Laboratories, Mississauga, ON, Canada). Membranes
were incubated with primary antibodies of appropriate
dilution as listed in Table 1, followed by the application
of appropriate horse radish peroxidase (HRP)-conjugated
secondary antibodies. Proteins were detected using
ECL™-Plus Western blot detection reagents (Perkin

Protein from PaSCs was extracted in a NP-40 lysis
buffer. Equal amount of protein from each experimental
group was fractionated by 7.5% or 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
www.impactjournals.com/oncotarget

14056

Oncotarget

Elmer, Wellesley, MA, USA) and imaged by the Versadoc
Imaging System (Bio-Rad Laboratories). Bands were
densitometrically quantified by Image Lab 3.0 software
(Bio-Rad Laboratories) and normalized to appropriate
loading controls [9, 13, 43].

pancreatic acini. Pancreas. 1997; 14: 373-82.
5.

Statistical analysis

Haber PS, Keogh GW, Apte MV, Moran CS, Stewart NL,
Crawford DH, Pirola RC, McCaughan GW, Ramm GA,
Wilson JS. Activation of pancreatic stellate cells in human
and experimental pancreatic fibrosis. Am J Pathol. 1999;
155: 1087-95.

6.

Hynes RO. Integrins: bidirectional, allosteric signaling
machines. Cell. 2002; 110: 673-87.

Data are expressed as mean ± SEM. Statistical
significance was determined using the paired Student’s
t-test when comparing two groups, or one-way ANOVA
followed by Tukey’s and/or Fisher’s least significant
difference post-hoc test when comparing more than two
groups using GraphPad Prism software program (Version
5.0c, GraphPad Software Inc., La Jolla, CA, USA) or
SPSS software (version 19.0, SPSS Inc, Chicago, IL,
USA). Differences were considered to be statistically
significant when p < 0.05.

7.

Brakebusch C, Fässler R. beta 1 integrin function in vivo:
adhesion, migration and more. Cancer Metastasis Rev.
2005; 24: 403-11.

8.

Juliano RL, Reddig P, Alahari S, Edin M, Howe A, Aplin A.
Integrin regulation of cell signalling and motility. Biochem
Soc Trans. 2004; 32: 443-6.

9.

Krishnamurthy M, Li J, Al-Masri M, Wang R. Expression
and function of alphabeta1 integrins in pancretic beta (INS1) cells. J Cell Commun Signal. 2008; 2: 67-79.

10. Riopel MM, Li J, Liu S, Leask A, Wang R. β1 integrinextracellular matrix interactions are essential for
maintaining exocrine pancreas architecture and function.
Lab Invest. 2013; 93: 31-40.
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